title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Geographic Atrophy Market to Boost Significantly, Assesses DelveInsight | Key Companies Active in the Domain - Novartis, Annexon, Apellis, Ionis, Astellas, Gyroscope, Genentech, Aviceda, Iveric Bio",20230628T210100,https://www.prnewswire.com/news-releases/geographic-atrophy-market-to-boost-significantly-assesses-delveinsight--key-companies-active-in-the-domain---novartis-annexon-apellis-ionis-astellas-gyroscope-genentech-aviceda-iveric-bio-301865699.html,OPT,0.051663,Neutral,-0.087948
Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update,20221101T195230,https://apnews.com/article/technology-health-business-covid-earnings-bdc3ab653efa6e90ce3521d3598ff4a0,OPT,0.010164,Neutral,-0.022914
Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer - Opthea  ( NASDAQ:OPT ) ,20221024T100000,https://www.benzinga.com/pressreleases/22/10/g29374702/opthea-expands-leadership-team-with-the-appointment-of-timothy-e-morris-as-chief-financial-officer,OPT,0.435433,Somewhat-Bullish,0.243961
Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer,20221024T100000,https://www.globenewswire.com/news-release/2022/10/24/2539753/0/en/Opthea-Expands-Leadership-Team-with-the-Appointment-of-Timothy-E-Morris-as-Chief-Financial-Officer.html,OPT,0.434285,Somewhat-Bullish,0.24362
"Earnings Scheduled For March 8, 2022",20220308T084513,https://www.benzinga.com/news/earnings/22/03/26032610/earnings-scheduled-for-march-8-2022,OPT,0.024658,Neutral,-0.045813
"Earnings Scheduled For May 10, 2022",20220510T091808,https://www.benzinga.com/news/earnings/22/05/27099859/earnings-scheduled-for-may-10-2022,OPT,0.015162,Neutral,-0.006025
Stocks That Hit 52-Week Lows On Wednesday,20220309T162916,https://www.benzinga.com/news/22/03/26063551/stocks-that-hit-52-week-lows-on-wednesday,OPT,0.05257,Neutral,-0.0116
"Vial Announces October Session of ""First in Human: The Panel Series"" Featuring Esteemed Panelists Jen Watts, Dr. Raj Agrawal, and Bruno Gagnon",20231001T230000,https://www.prnewswire.com/news-releases/vial-announces-october-session-of-first-in-human-the-panel-series-featuring-esteemed-panelists-jen-watts-dr-raj-agrawal-and-bruno-gagnon-301943750.html,OPT,0.118064,Neutral,0.082018
